Liver and COVID-19: From care of patients with liver diseases to liver injury
World J Hepatol. 2021 Oct 27;13(10):1367-1377. doi: 10.4254/wjh.v13.i10.1367.ABSTRACTThe global pandemic of coronavirus disease 2019 (COVID-19) changed dramatically all priorities on medical society and created several challenges for clinicians caring for patients with liver diseases. We performed a comprehensive review about how COVID-19 can affect the liver, the influence of liver diseases on the risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 severity and also some strategies to overcome all the challenges clinicians have to face in the management of patients with liver diseases in a period of time when all the focus turned on COVID-19. We analyze the relationship between COVID-19 and non-alcoholic fatty liver disease, alcoholic liver disease, viral hepatitis, autoimmune liver disease, cirrhosis, hepatocellular carcinoma and liver transplantation, as well as the approach to SARS-CoV-2 vaccination.PMID:34786172 | PMC:PMC8568576 | DOI:10.4254/wjh.v13.i10.1367
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Rui Gaspar Catarina Castelo Branco Guilherme Macedo Source Type: research
More News: Alcoholism | Autoimmune Disease | Cancer & Oncology | Carcinoma | Cirrhosis | Coronavirus | COVID-19 | Fatty Liver Disease (FLD) | Gastroenterology | Hepatitis | Hepatitis Vaccine | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Pandemics | Respiratory Medicine | SARS | Transplants | Urology & Nephrology | Vaccines